ArticlePDF Available
Letters to the Editor
Annals of Indian Academy of Neurology ¦ Volume 25 ¦ Issue 3 ¦ May-June 2022
562
Sir,
Leukodystrophies usually manifest as childhood‑onset
disorders; however, adult‑onset presentations are not rare.
Intriguingly, mutations of the TUBB4A gene are associated
with two apparently distinct syndromes—one presenting
as an adult‑onset genetic dystonia, while the other as a
childhood‑onset hypomyelinating disorder.[1,2] Herein, we
present a case of TUBB4Amutation demonstrating an atypical
phenotype, which indicates a clinico‑radiological intermediate
between the two syndromes. It also illustrates the importance
of regular follow‑up in such patients as they may accrue new
symptoms requiring adequate management.
A 61‑year‑old unmarried lady, without any known
comorbidities or any family history of seizures or movement
disorders, presented with gradually progressive dystonia, gait
impairment, dysarthria, and cognitive decline, along with
new onset seizure. Symptoms started about 20 years ago, in
the form of cervical dystonia (right torticollis) along with
tremulousness of the head, which was more pronounced during
any activity like nodding her head or looking to a particular
side. Later, it persisted even at rest and gradually progressed
over years to involve the limbs (which was noticed by her as
diculty in cooking and holding utensils with posturing of
limbs); however, she did not notice any sensory tricks. She
developed progressive gait unsteadiness and stiness for the
last 10 years and ultimately required aid for ambulation. This
was followed by dysarthria without any spasmodic dysphonia.
For the last 5 years, there has been progressive impairment of
attention, executive function, and memory reported as diculty
in keeping track of conversation, frequent diculty in recalling
recent events, and tendency to skip steps in performing an
activity, leading to errors. She developed two episodes of
new onset seizure (generalized tonic clonic convulsions) a
few days before her admission. On admission, her MoCA
score was 22; there was predominantly cervical dystonia
with dystonic head tremor, and spasticity and hyperreexia
in all four limbs [Video 1]. Ophthalmological evaluation and
other cranial nerves were essentially normal. Investigations
revealed normal blood parameters (including complete
blood count, erythrocyte sedimentation rate, urea, creatinine,
sodium, potassium, calcium, glucose, and liver and thyroid
function tests), parathormone, ceruloplasmin, and ferritin
values. Nerve conduction study and electroencephalography
were normal. Magnetic resonance imaging of the brain
revealed T2/uid‑attenuated inversion recovery sequence and
hyperintensity of subcortical white matter with diuse cortical
atrophy [Figure 1]. Considering genetic disorders such as
adult‑onset leukodystrophy, clinical exome sequencing was
performed, which revealed a heterozygous pathogenic variant
in exon 4 of the TUBB4A gene, c.286G>A(p.Gly96Arg).
She was treated symptomatically with levetiracetam (1500 mg),
trihexyphenidyl (8 mg), and baclofen (30 mg) and had
no further episodes of seizures with some reduction in
dystonia (especially in the limbs) and spasticity. The patient
is being followed up at the institute for the last 1 year,
and botulinum toxin therapy has not been tried as she had
responded to medications and was reluctant for botox therapy.
TUBB4A (cytogenetic location: 19p13.3) (tubulin beta‑4A gene)
encodes a brain‑specic member of beta‑tubulin family, highly
expressed in the cerebellum, putamen, and white matter.[1]
Mutations of the TUBB4A, on the one end of the spectrum, are
associated with adult‑onset genetic dystonia without signicant
MRI changes (DYT 4, MIM #128101).[1,3] At the other end, it
is associated with hypomyelinating leukodystrophy‑6 (MIM
#612438) or hypomyelination with atrophy of the basal ganglia
and cerebellum (H‑ABC) with clinical and radiological traits
of hypomyelination, cerebellar atrophy, and progressive
atrophy of the neostriatum (caudate and putamen), which
Adult-Onset Dystonia with Late-Onset Epilepsy in
TUBB4A-Related Hypomyelinating Leukodystrophy—A New
Intermediate Phenotype
Figure 1: Hypomyelination with cerebellar and cortical atrophy. Magnetic
resonance imaging of brain—axial T2-weighted (a), T2 fluid-attenuated
inversion recovery (b), T1-weighted (c), and sagittal T2-weighted
(d) images: showing symmetrical white matter signal intensity
changes—hyperintense on T2/FLAIR (arrows) and isointense on T1,
with cerebellar and cortical atrophy
d
c
b
a
Letters to the Editor
Annals of Indian Academy of Neurology ¦ Volume 25 ¦ Issue 3 ¦ May-June 2022 563
Contd...
Table 1: Studies elaborating prominent clinical radiological and genetic features of TUBB4A disease spectrum
Name of study Total number of
patients
Clinico-radiological profile Mutation
Movement disorder Other neurological
findings
Other system
findings
Radiology
1) Erro R, et al. H‑ABC
syndrome and DYT4:
Variable expressivity or
pleiotropy of TUBB4
mutations (2015)[6]
04 (age of onset
rst decade of life)
Generalized dystonia, ataxia.
Bulbar involvement leading
to aphonia and swallowing
diculty.
Spasticity, non‑development
of communication skills with
preserved comprehension.
Hypomyelination of cerebellum
with atrophy of basal ganglia
except two cases: One did not
show hypomyelination and the
other did not show basal ganglia
atrophy.
One previously described and
two novel mutations (c.941C
>T; p.Ala314Val and c.900G
>T; p.Met300Ile) in the exon 4
of the gene.
Whispering dysphonia in one
patient.
Oculogyric crises
2) Hamilton EM, et al.
Hypomyelination with
atrophy of the basal ganglia
and cerebellum: Further
delineation of the phenotype
and genotype‑phenotype
correlation. (2014)[7]
42 (median age
of onset was 6
months, (range
birth–3 years))
Dystonia, choreoathetosis
(rarely)
Developmental delay,
nystagmus, loss of speech
from median age 7 years.
Most patients unable to
ambulate by the second
decade. Ryles tube feeding
required in 58% of patients.
Absent or disappearing
putamen, variable cerebellar
atrophy, and highly
variable cerebral atrophy.
Hypomyelination, agenesis of
corpus callosum.
25 patients, a heterozygous
c.745G >A TUBB4A mutation
was identied. Thirteen other
TUBB4A mutations were
identied in 17 patients always
in the heterozygous state.
3) Blumkin L, et al.
Expansion of the spectrum of
TUBB4A‑related disorders:
A new phenotype associated
with a novel mutation in the
TUBB4A gene. (2014)[8]
01 Segmental dystonia. Slowly progressive spastic
paraparesis.
Intellectual disability
Permanent, incomplete
myelination associated with
progressive cerebellar atrophy
Novel E410K de novo
heterozygous mutation in the
TUBB4A gene
Whispering dystonia: Present.
4) Lohmann K,
et al. Whispering
dysphonia (DYT4 dystonia)
is caused by a mutation in
the TUBB4 gene. (2013)[3]
Whispering dysphonia:
Present. Focal or generalized
dystonia.
. Distinctive
facies and
body habitus.
Disease‑causing gene was
mapped to a 23cM region on
chromosome 19p13.3‑p13.2
Missense variant in the
TUBB4 (tubulin beta‑4;
Arg2Gly).
5) Simons C, et al. A de novo
mutation in the β‑tubulin
gene TUBB4A results in
the leukoencephalopathy
hypomyelination with
atrophy of the basal ganglia
and cerebellum. (2013)[9]
11 (9 months to
4.5 years: age of
onset)
Hemidystonia. Ataxia
with gait progressively
deteriorating in all cases
Motor delayed
developmental milestones.
MRI suggestive of
hypomyelination with basal
ganglia atrophy.
Heterozygous de novo mutation
in TUBB4A was identied in
all aected individuals: 745G
>A (g. 6495765C >T)
Dysarthria causing
communication diculty
with preserved language and
cognitive domains
Letters to the Editor
Annals of Indian Academy of Neurology ¦ Volume 25 ¦ Issue 3 ¦ May-June 2022
564
Table 1: Contd...
Name of study Total number of
patients
Clinico-radiological profile Mutation
Movement disorder Other neurological
findings
Other system
findings
Radiology
6) Wilcox RA, et al.
Whispering dysphonia in an
Australian family (DYT4):
A clinical and genetic
reappraisal. (2011)[10]
One family with
nine aected
members.
Isolated spasmodic dysphonia
(whispering dysphonia) often
with mild craniocervical
dystonia to severe generalized
dystonia. Extrusional tongue
dystonia and a unique “hobby
horse gait.”
Missense (c.2297C >G;
p.T766R) and a splice‑site
mutation (IVS5 + 1G >T) were
identied.
7) Lu Y, Ondo Y, Shimojima
K, Osaka H, Yamamoto T.
A novel TUBB4A mutation
G96R identied in a patient
with hypomyelinating
leukodystrophy onset beyond
adolescence. (2017)[5]
01 (onset after age
of 17)
Ataxia, dystonia without
dysphonia
MRI ndings suggestive of
hypomyelination of cerebellum,
without signicant basal ganglia
atrophy.
TUBB4A: c. 86G >A [p.Gly (G)
96Arg (R)] was detected in
the conserved region (de novo
mutation).
8) Tonduti D,
TUBB4A‑related
hypomyelinating
leukodystrophy: New
insights from a series of
12 patients. (2016).[2]
12 patients (disease
onset at a mean age
of 19 months (range
3 months–5 years).
Dystonia, 2 had a severe
hypokinetic‑rigid syndrome,
1 manifested only postural
tremor.
Motor delayed
developmental milestones.
Dysarthria/anarthria, spastic
diplegia with cerebellar
signs, spastic paraplegia,
ataxia, spastic tetraparesis.
1 had
hypodontia and
1 manifested
type 1 diabetes
mellitus.
White matter hypomyelination,
while cerebellar atrophy. 1
image showed “globular”
appearance of the basal ganglia
because the anterior limb
of internal capsule was not
recognizable on FLAIR
1) 6 carried the mutation
c.731G >T (p.Gly244Val)
2) 1 showed the nucleotide
change c. 1163T >C leading
to the amino acid change
Met388Thr.
3) Novel mutations—c. 544C
>A (p.Pro182Thr), c. 533C
>T (p.Thr178Met), c. 731G
>A (p.Gly244Asp) missense
mutation
Letters to the Editor
Annals of Indian Academy of Neurology ¦ Volume 25 ¦ Issue 3 ¦ May-June 2022 565
usually presents in children.[2,4] Our patient was unique
in terms of age of disease onset and temporal prole of
symptomatology. Her onset of symptoms was in the fth
decade, when she initially had dystonia and was in the DYT4
range of the spectrum, although without typical “whispering
dysphonia.” After she developed ataxia, spasticity, cognitive
impairment, and eventually, seizures, and her MRI being
suggestive of hypomyelination, she manifested features in
the H‑ABC range of the spectrum. Previously, the same
mutation [c.286G>A(p.Gly96Arg)] was demonstrated in a
Japanese patient with hypomyelinating leukodystrophy, whose
symptoms started in the second decade with spasticity and
dystonia.[5] An overview of the various studies on TUBB4A
mutation disease spectrum with their prominent clinical
ndings is given in Table 1. Notably, our patient had a much
later onset and, additionally, developed seizures. One patient
of spasmodic dysphonia and oromandibular dystonia and
dyskinesia with p.Ala271Thr variant of TUBB4A had onset at
60 years.[3] However, there was no history of ataxia or seizures.
Therefore, this patient represents a new phenotype associated
with TUBB4A mutation, as a hypomyelinating leukodystrophy
with very late age of onset, starting as dystonia, progressing
over decades, and finally manifesting seizures, thus
highlighting the role of thorough investigation and long‑term
follow‑up in such patients.
Declaration of patient consent
Written informed consent was duly obtained.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conicts of interest.
Peyalee Sarkar, Adreesh Mukherjee, Sumanta Sarkar, Raju Agrawal,
Souvik Dubey, Alak Pandit
Bangur Institute of Neurosciences, Institute of Post Graduate Medical Education
and Research, Kolkata, West Bengal, India
Address for correspondence: Dr. Adreesh Mukherjee,
2-B, Surja Kumar Chatterjee Street, Kolkata, West Bengal, India.
E-mail: adreesh03@yahoo.co.in
RefeRences
1. Hersheson J, Mencacci NE, Davis M, MacDonald N, Trabzuni D,
Ryten M, et al. Mutations in the autoregulatory domain of β‑tubulin 4a
cause hereditary dystonia. Ann Neurol 2013;73:546‑53.
2. Tonduti D, Aiello C, Renaldo F, Dorboz I, Saaman S, Rodriguez D,
et al. TUBB4A‑related hypomyelinating leukodystrophy: New
insights from a series of 12 patients. Eur J Paediatr Neurol
2016;20:323‑30.
3. Lohmann K, Wilcox RA, Winkler S, Ramirez A, Rakovic A, Park J‑S,
et al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation
in the TUBB4 gene. Ann Neurol 2013;73:537‑45.
4. Ferreira C, Poretti A, Cohen J, Hamosh A, Naidu S. Novel
TUBB4A mutations and expansion of the neuroimaging phenotype
of hypomyelination with atrophy of the basal ganglia and
cerebellum (H‑ABC). Am J Med Genet A 2014;164:1802‑7.
5. Lu Y, Ondo Y, Shimojima K, Osaka H, Yamamoto T. A novel
TUBB4A mutation G96R identied in a patient with hypomyelinating
leukodystrophy onset beyond adolescence. Hum Genome Var
2017;4:17035.
6. Erro R, Hersheson J, Ganos C, Mencacci NE, Stamelou M, Batla A,
et al. H‑ABC syndrome and DYT4: Variable expressivity or pleiotropy
of TUBB4 mutations? Mov Disord 2015;30:828‑33.
7. Hamilton EM, Polder E, Vanderver A, Naidu S, Schimann R, Fisher K,
et al. Hypomyelination with atrophy of the basal ganglia and cerebellum:
Further delineation of the phenotype and genotype‑phenotype
correlation. Brain 2014;137:1921‑30.
8. Blumkin L, Halevy A, Ben‑Ami‑Raichman D, Dahari D, Haviv A,
Sarit C, et al. Expansion of the spectrum of TUBB4A‑related disorders:
a new phenotype associated with a novel mutation in the TUBB4A
gene. Neurogenetics 2014;15:107‑13. doi: 10.1007/s10048‑014‑0392‑
2. Erratum in: Neurogenetics 2014;15:115.
9. Simons C, Wolf NI, McNeil N, Caldovic L, Devaney JM, Takanohashi A,
et al. A de novo mutation in the β‑tubulin gene TUBB4A results in the
leukoencephalopathy hypomyelination with atrophy of the basal ganglia
and cerebellum. Am J Hum Genet 2013;92:767‑73.
10. Wilcox RA, Winkler S, Lohmann K, Klein C. Whispering dysphonia in
an Australian family (DYT4): A clinical and genetic reappraisal. Mov
Disord 2011;26:2404‑8.
This is an open access journal, and arcles are distributed under the terms of the Creave Commons
Aribuon‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build
upon the work non‑commercially, as long as appropriate credit is given and the new creaons are
licensed under the idencal terms.
DOI: 10.4103/aian.aian_952_21
Submitted: 31‑Oct‑2021 Revised: 02‑Jan‑2022 Accepted: 14‑Jan‑2022
Published: 20‑Apr‑2022
Video available on: www.annalsoan.org
The Temporal Course of the MRI Findings of Inferior Oliver
Hypertrophy: The Clinicoradiologic Presentation of a Rare
Patient with Holmes Tremor and Palatal Myoclonus
Dear Editor,
A 44‑year‑old male patient was admitted to our polyclinic
due to a left‑sided tremor that had started six months ago and
progressed gradually. The patient had a history of pontine
hemorrhagic stroke 15 months ago, and he was immobile due to
severe truncal ataxia since then. However, this readmission was
due to newly‑onset left‑sided tremor, and further interrogation
of the medical history revealed that the patient had also been
suering from clicking noises, and muscle spasms at the back
of the throat within this period. The neurological exam showed
right‑sided peripheral type facial paralysis and slight paralysis
on the left upper and lower extremities that were evaluated as
... [12] An intermediate phenotype between H-ABC and DYT-TUBB4A has been previously reported from India. [13] TUBB4A encodes for beta-tubulin 4A protein, which is a contributor to microtubule polymerization and stability. Laryngeal involvement is seen in patients with generalized and segmental dystonia, including DYT1, DYT6, DYT25, and DYT28, although it is rarely a presenting feature in these patients, unlike DYT4. ...
... However, the asymmetrical involvement of the brain would not be typical for a leukodystrophy, although the field of genetically defined mitochondrial leukodystrophies continues to expand [35]. Moreover, for some recently described genetically defined leukodystrophies with adult onset, neuropathological correlation was not available or has not been reported [4,36]. ...
Article
Full-text available
We report the case of a 22-year-old woman presenting with an acute onset of dizziness, gait dysbalance and blurred vision. Magnetic resonance imaging included 3 Tesla and 7 Tesla imaging and revealed a T2-hyperintense, T1-hypointense, non-contrast-enhancing lesion strictly confined to the white matter affecting the right optic radiation. An extensive ophthalmologic examination yielded mild quadrantanopia but no signs of optic neuropathy. The lesion was biopsied. The neuropathological evaluation revealed a demyelinating lesion with marked tissue vacuolization and granular myelin disintegration accompanied by mild T cell infiltration and a notable absence of myelin uptake by macrophages. Oligodendrocytes were strikingly enlarged, displaying oncocytic characteristics and showed cytoplasmic accumulation of mitochondria, which had mildly abnormal morphology on electron microscopy. The diagnosis of multiple sclerosis was excluded. Harding's disease, a variant of Leber's hereditary optic neuropathy, was then suspected. However, neither PCR for relevant mutations nor whole exome sequencing yielded known pathogenetic mutations in the patient's genome. We present a pattern of demyelinating tissue injury of unknown etiology with an oncocytic change of oligodendrocytes and a lack of adequate phagocytic response by macrophages, which to the best of our knowledge, has not been described before.
Article
Full-text available
Functional gene embeddings, numerical vectors capturing gene function, provide a promising way to integrate functional gene information into machine learning models. These embeddings are learnt by applying self-supervised machine-learning algorithms on various data types including quantitative omics measurements, protein–protein interaction networks and literature. However, downstream evaluations comparing alternative data modalities used to construct functional gene embeddings have been lacking. Here we benchmarked functional gene embeddings obtained from various data modalities for predicting disease-gene lists, cancer drivers, phenotype–gene associations and scores from genome-wide association studies. Off-the-shelf predictors trained on precomputed embeddings matched or outperformed dedicated state-of-the-art predictors, demonstrating their high utility. Embeddings based on literature and protein–protein interactions inferred from low-throughput experiments outperformed embeddings derived from genome-wide experimental data (transcriptomics, deletion screens and protein sequence) when predicting curated gene lists. In contrast, they did not perform better when predicting genome-wide association signals and were biased towards highly-studied genes. These results indicate that embeddings derived from literature and low-throughput experiments appear favourable in many existing benchmarks because they are biased towards well-studied genes and should therefore be considered with caution. Altogether, our study and precomputed embeddings will facilitate the development of machine-learning models in genetics and related fields.
Article
Full-text available
The tubulin beta-4A gene (TUBB4A) is associated with two different clinical conditions, dystonia type 4 (DYT4) and hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). We identified a novel TUBB4A mutation, c.286G>A (p.G96R), in an adult male patient who suffered neurological symptoms beyond adolescence. This patient shows intermediate clinical features between DYT4 and H-ABC, suggesting that the TUBB4A disorder would constitute a spectrum disorder.
Article
Full-text available
Hypomyelination with atrophy of the basal ganglia and cerebellum is a rare leukoencephalopathy that was identified using magnetic resonance imaging in 2002. In 2013, whole exome sequencing of 11 patients with the disease revealed that they all had the same de novo mutation in TUBB4A, which encodes tubulin β-4A. We investigated the mutation spectrum in a cohort of 42 patients and the relationship between genotype and phenotype. Patients were selected on the basis of clinical and magnetic resonance imaging abnormalities that are indicative of hypomyelination with atrophy of the basal ganglia and cerebellum. Genetic testing and a clinical inventory were performed, and sequential magnetic resonance images were evaluated using a standard protocol. The heterozygous TUBB4A mutation observed in the first 11 patients was the most common (25 patients). Additionally, 13 other heterozygous mutations were identified, located in different structural domains of tubulin β-4A. We confirmed that the mutations were de novo in all but three patients. In two of these three cases we lacked parental DNA and in one the mutation was also found in the mother, most likely due to mosaicism. Patients showed a phenotypic continuum ranging from neonatal to childhood disease onset, normal to delayed early development and slow to more rapid neurological deterioration. Neurological symptomatology consisted of extrapyramidal movement abnormalities, spasticity, ataxia, cognitive deficit and sometimes epilepsy. Three patients died and the oldest living patient was 29 years of age. The patients' magnetic resonance images showed an absent or disappearing putamen, variable cerebellar atrophy and highly variable cerebral atrophy. Apart from hypomyelination, myelin loss was evident in several cases. Three severely affected patients had similar, somewhat atypical magnetic resonance image abnormalities. The study results were strongly suggestive of a genotype-phenotype correlation. The 25 patients with the common c.745G>A mutation generally had a less rapidly progressive disease course than the 17 cases with other TUBB4A mutations. Overall, this work demonstrates that the distinctive magnetic resonance imaging pattern for hypomyelination with atrophy of the basal ganglia and cerebellum defines a homogeneous clinical phenotype of variable severity. Patients almost invariably have prominent extrapyramidal movement abnormalities, which are rarely seen in patients with hypomyelination of different origin. A dominant TUBB4A mutation is also associated with dystonia type 4, in which magnetic resonance images of the brain seem normal. It is highly likely that there is a disease continuum associated with TUBB4A mutations, of which hypomyelination with atrophy of the basal ganglia and cerebellum and dystonia type 4 are the extremes. This would indicate that extrapyramidal movement abnormalities constitute the core feature of the disease spectrum related to dominant TUBB4A mutations and that all other features are variable.
Article
Full-text available
Mutations in the TUBB4A gene have been identified so far in two neurodegenerative disorders with extremely different clinical features and course: whispering dysphonia, also known as dystonia type 4 (DYT4), and hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). We describe a patient with slowly progressive spastic paraparesis, segmental dystonia, intellectual disability, behavioral problems, and evidence of permanent, incomplete myelination associated with progressive cerebellar atrophy. Whole exome sequencing revealed a novel E410K de novo heterozygous mutation in the TUBB4A gene. The clinical and radiological picture of our patient is different from the classic phenotype; thus, it expands the phenotypic variation of TUBB4A-gene-related disorders.
Article
Full-text available
Dystonia type 4 (DYT4) was first described in a large family from Heacham in Norfolk with an autosomal dominantly inherited whispering dysphonia, generalized dystonia, and a characteristic hobby horse ataxic gait. We carried out a genetic linkage analysis in the extended DYT4 family that spanned 7 generations from England and Australia, revealing a single LOD score peak of 6.33 on chromosome 19p13.12-13. Exome sequencing in 2 cousins identified a single cosegregating mutation (p.R2G) in the β-tubulin 4a (TUBB4a) gene that was absent in a large number of controls. The mutation is highly conserved in the β-tubulin autoregulatory MREI (methionine-arginine-glutamic acid-isoleucine) domain, highly expressed in the central nervous system, and extensive in vitro work has previously demonstrated that substitutions at residue 2, specifically R2G, disrupt the autoregulatory capability of the wild-type β-tubulin peptide, affirming the role of the cytoskeleton in dystonia pathogenesis. Ann Neurol 2013.
Article
Background: Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) was first described in 2002. After the recent identification of TUBB4A mutation as the genetic basis of the disease, the clinical and neuroimaging phenotype related to TUBB4A mutations expanded, ranging from primary dystonia type 4 with normal MRI to severe H-ABC cases. Patients and methods: The study included patients referred to us for an unclassified hypomyelinating leukodystrophy. We selected patients with deleterious heterozygous TUBB4A mutations. Molecular analysis of TUBB4A was performed on genomic DNA extracted from peripheral blood. Results: The series included 12 patients (5 females and 7 males). Five patients carried the common mutation c.745G > A (p.Asp249Asn), while the remaining harbored different mutations. Three new mutations were found in 5 patients. Clinical and neuroimaging observations are described. A clear correlation between the clinical presentation and the genotype seems to be absent in our group of 12 patients. Conclusions: TUBB4A-mutated patients manifest a comparable clinical and neuroimaging picture but they can differ from each other in terms of rate of disease progression. Extrapyramidal signs can be absent in the first stages of the disease, and a careful evaluation of MRI is fundamental to obtain the final diagnosis. From a therapeutic perspective a trial with l-dopa should be considered in all patients presenting extrapyramidal symptoms.
Article
Recently, mutations in the TUBB4A gene have been found to underlie hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome, a rare neurodegenerative disorder of infancy and childhood. TUBB4A mutations also have been described as causative of DYT4 (“hereditary whispering dysphonia”). However, in DYT4, brain imaging has been reported to be normal and, therefore, H-ABC syndrome and DYT4 have been construed to be different disorders, despite some phenotypic overlap. Hence, the question of whether these disorders reflect variable expressivity or pleiotropy of TUBB4A mutations has been raised. We report four unrelated patients with imaging findings either partially or totally consistent with H-ABC syndrome, who were found to have TUBB4A mutations. All four subjects had a relatively homogenous phenotype characterized by severe generalized dystonia with superimposed pyramidal and cerebellar signs, and also bulbar involvement leading to complete aphonia and swallowing difficulties, even though one of the cases had an intermediate phenotype between H-ABC syndrome and DYT4. Genetic analysis of the TUBB4A gene showed one previously described and two novel mutations (c.941C>T; p.Ala314Val and c.900G>T; p.Met300Ile) in the exon 4 of the gene. While expanding the genetic spectrum of H-ABC syndrome, we confirm its radiological heterogeneity and demonstrate that phenotypic overlap with DYT4. Moreover, reappraisal of previously reported cases would also argue against pleiotropy of TUBB4A mutations. We therefore suggest that H-ABC and DYT4 belong to a continuous phenotypic spectrum associated with TUBB4A mutations. © 2014 International Parkinson and Movement Disorder Society
Article
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) has recently been associated with a single heterozygous p.D249N mutation in TUBB4A. We describe two novel mutations in this gene. A p.C239F mutation was found in one of the originally described H-ABC patients, for whom we provide follow-up 11 years after the original publication. The second novel mutation, p.R262H, was found in a patient with a typical clinical presentation for H-ABC, but with a novel neuroimaging phenotype, given the absence of atrophy of the putamen and caudate nucleus despite 7 years of follow-up. The recent recognition of TUBB4A mutations as the underlying etiology of H-ABC will likely lead to the identification of subtler clinical and neuroimaging presentations of this disorder, like in our third patient. Thus mutations in this gene should be suspected in any patient with hypomyelination, regardless of the long-term presence of neostriatal atrophy. © 2014 Wiley Periodicals, Inc.
Article
Objective: A study was undertaken to identify the gene underlying DYT4 dystonia, a dominantly inherited form of spasmodic dysphonia combined with other focal or generalized dystonia and a characteristic facies and body habitus, in an Australian family. Methods: Genome-wide linkage analysis was carried out in 14 family members followed by genome sequencing in 2 individuals. The index patient underwent a detailed neurological follow-up examination, including electrophysiological studies and magnetic resonance imaging scanning. Biopsies of the skin and olfactory mucosa were obtained, and expression levels of TUBB4 mRNA were determined by quantitative real-time polymerase chain reaction in 3 different cell types. All exons of TUBB4 were screened for mutations in 394 unrelated dystonia patients. Results: The disease-causing gene was mapped to a 23cM region on chromosome 19p13.3-p13.2 with a maximum multipoint LOD score of 5.338 at markers D9S427 and D9S1034. Genome sequencing revealed a missense variant in the TUBB4 (tubulin beta-4; Arg2Gly) gene as the likely cause of disease. Sequencing of TUBB4 in 394 unrelated dystonia patients revealed another missense variant (Ala271Thr) in a familial case of segmental dystonia with spasmodic dysphonia. mRNA expression studies demonstrated significantly reduced levels of mutant TUBB4 mRNA in different cell types from a heterozygous Arg2Gly mutation carrier compared to controls. Interpretation: A mutation in TUBB4 causes DYT4 dystonia in this Australian family with so-called whispering dysphonia, and other mutations in TUBB4 may contribute to spasmodic dysphonia. Given that TUBB4 is a neuronally expressed tubulin, our results imply abnormal microtubule function as a novel mechanism in the pathophysiology of dystonia.
Article
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) is a rare hereditary leukoencephalopathy that was originally identified by MRI pattern analysis, and it has thus far defied all attempts at identifying the causal mutation. Only 22 cases are published in the literature to date. We performed exome sequencing on five family trios, two family quartets, and three single probands, which revealed that all eleven H-ABC-diagnosed individuals carry the same de novo single-nucleotide TUBB4A mutation resulting in nonsynonymous change p.Asp249Asn. Detailed investigation of one of the family quartets with the singular finding of an H-ABC-affected sibling pair revealed maternal mosaicism for the mutation, suggesting that rare de novo mutations that are initially phenotypically neutral in a mosaic individual can be disease causing in the subsequent generation. Modeling of TUBB4A shows that the mutation creates a nonsynonymous change at a highly conserved asparagine that sits at the intradimer interface of α-tubulin and β-tubulin, and this change might affect tubulin dimerization, microtubule polymerization, or microtubule stability. Consistent with H-ABC's clinical presentation, TUBB4A is highly expressed in neurons, and a recent report has shown that an N-terminal alteration is associated with a heritable dystonia. Together, these data demonstrate that a single de novo mutation in TUBB4A results in H-ABC.
Article
The designation, DYT4, was assigned to an Australian family with whispering dysphonia. The role of known causes of dystonia has not been comprehensively investigated in this family, nor has the possible relationship with Wilson disease (WND) in 2 siblings. Eighteen family members were neurologically examined, and DNA samples were obtained. Linkage analysis was performed to DYT1, DYT6, DYT7, DYT11, DYT13, DYT15, and ATP7B with microsatellite markers and the THAP1 (DYT6), PRKRA (DYT16), and ATP7B (WND) genes were sequenced. Reevaluation of the family identified 9 living affected family members, 6 of whom are newly affected. Phenotypic expression was variable, ranging from isolated spasmodic dysphonia (often with mild craniocervical dystonia) to severe generalized dystonia. Two newly described features included an extrusional tongue dystonia and a unique “hobby horse gait.” Genetic analyses excluded all tested loci. Haplotype analysis of the ATP7B region resulted in three different combinations of the two parental alleles in the 8 investigated siblings of the 2 deceased WND patients, indicating that the fourth combination (of two mutated alleles) had occurred only in the deceased WND patients. On these two alleles, we identified a missense (c.2297C>G; p.T766R) and a splice-site mutation (IVS5+1G>T). The c.2297C>G mutation was detected in 3 affected and 4 unaffected family members, whereas the IVS5+1G>T mutation was detected in 1 affected and unaffected family member. Five DYT4 patients carried neither mutation. DYT4 is a familial form of dystonia unrelated to known dystonia genes and loci. ATP7B mutations do not segregate with the dystonia phenotype, indicating two independent genetic diseases in this family. © 2011 Movement Disorder Society